|4Feb 2, 5:03 PM ET

Jounce Therapeutics, Inc. 4

4 · Jounce Therapeutics, Inc. · Filed Feb 2, 2017

Insider Transaction Report

Form 4
Period: 2017-02-01
Transactions
  • Purchase

    Common Stock

    2017-02-01$16.00/sh+6,700$107,20027,025 total

Documents

1 file
  • 4
    a4.xmlPrimary

    4